ADM Ventures has invested in Seventure’s Health for Life Capital (HFLC) Fund II.

HFLC is a Paris-based, microbiome-focused fund, which invests in health, nutrition, microbiota and digital health sectors.

The microbiome consists of trillions of micro-organisms and is present on or inside the human body.

ADM said that it primarily focuses on microbiomes present in the complex bacterial ecosystem that is present within the digestive tract.

ADM Ventures managing director Darren Streiler said: “With a better understanding of how the microbiome ecosystem works, we can develop functional ingredients for dietary supplements and food and beverage solutions targeted to help improve overall health.

“We are focused on looking at new, innovative solutions that can lead to a more balanced bacterial system in your digestive tract, otherwise known as a healthy gut, and can help lead to better health.

To further strengthen its position in the microbiome solutions segment, ADM is also constructing a new probiotics production facility in Valencia, Spain.

The facility is expected to commence production in 2022 and increase the company’s post-biotic and prebiotic production capacity.

Streiler added: “We view Seventure as the premier investor in microbiome startups focused on human health and nutrition, and since 2018, ADM has worked closely with the Seventure team to identify opportunities with microbiome solutions that can ultimately help with dietary supplements and food and beverage applications to serve as functional or proactive solutions.

“We believe Seventure can help meet the long-term demand we see as the result of the convergence of food and pharmaceuticals and consumers looking more towards bioactives and nutrition for wellness solutions.”